Symposia
Sunday, 29 May 2011
17.30 – 19.30
Presidential Symposium Treatment of muscle diseases:
The future is already here
Z. Argov (Jerusalem, IL)
Can we bypass a muscle metabolic defect?
Exercise therapy in muscle disease: A current overview
Antisense therapy of muscular dystrophies
Gene therapy for myopathies
Monday, 30 May 2011
09.00 – 11.00
Symposium Molecular and cellular mechanisms of ischaemic stroke
G. Stoll (Würzburg, DE)
J. Ferro (Lisbon, PT)
This symposium is given in collaboration between the ENS and ESO.
J. Ferro (Lisbon, PT)
This symposium is given in collaboration between the ENS and ESO.
Novel molecular targets for acute stroke treatment
Brain-immune interactions, infection, and inflammation in acute stroke
Hypothermia: From animal models and translation to humans
Stem cells in experimental stroke: Translation to humans?
09.00 – 11.00
Symposium Psychiatric aspects of neurological disorders
H. Förstl (Munich, DE)
Behaviour and theory of mind in frontotemporal dementia
Psychiatric aspects of PSP, MSA and ALS
Psychiatric symptoms in Parkinson’s disease
Behavioural and psychological symptoms of dementia (BPSD) in Alzheimer’s disease: Update on management
Tuesday, 31 May 2011
09.00 – 11.00
Symposium Metals and movement disorders
Chair: P. Taba (Tartu, EE)
Wilson’s disease
Neurodegeneration with brain iron accumulation (NBIA) syndroms
Manganese-related movement disorders
Metal ions and neurodegeneration
09.00 – 11.00
Symposium Biomarkers for diagnosis, prognosis and response to treatment in MS
Chair: R. Martin (Hamburg, DE)
Transcriptomics
Genetic markers
CSF markers
Magnetic resonance imaging
